Search - tctmd.com

Displaying 121 - 140 of 149

Sort: Relevancy | Date

News Daily News

Un Registro Coreano Confirma la Superioridad de los Stents liberadores de Everolimus sobre los de Zotarolimus

September 19, 2012

News Daily News

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

September 19, 2012

News Daily News

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

Yael L. Maxwell

September 07, 2012

News Daily News

SORT OUT IV: El Xience Aguanta el Tirón del Cypher en la Prevención de la Trombosis del Stent

Yael L. Maxwell

September 07, 2012

News Daily News

SORT OUT III: Riesgo más alto de trombosis del stent muy tardía con Cypher en comparación con Endeavor

L.A. McKeown

August 23, 2012

News Daily News

SORT OUT III: Higher Risk of Very Late Stent Thrombosis with Cypher vs. Endeavor

L.A. McKeown

August 23, 2012

News Daily News

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

L.A. McKeown

July 30, 2012

News Daily News

Xience V Noninferior to Cypher for Primary PCI

July 24, 2012

News Daily News

Meta-analysis: Less Stent Thrombosis at 2 Years with EES vs. Other DES

Leah Lawrence

June 15, 2012

News Daily News

Meta Análisis: Menor Trombosis del Stent a los 2 Años con SLE que con Otro Tipo de SLF

Leah Lawrence

June 15, 2012

News Daily News

Meta-analysis: Superior Efficacy with DES at No Cost to Safety

May 22, 2012

News Daily News

Meta Análisis: Superior Eficacia de los SLF sin poner en Peligro la Seguridad

May 22, 2012

News Daily News

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

Caitlin E. Cox

March 25, 2012

News Daily News

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

Caitlin E. Cox

March 25, 2012

News Daily News

SES Effective for Both Focal, Diffuse DES Restenosis

March 13, 2012

News Daily News

TCTMD’s Top 10 Most Popular News Stories From 2011

Jason Kahn

March 08, 2012

News Daily News

Stent Thrombosis Risk Lower with Xience vs. First-Generation DES

Yael L. Maxwell

March 06, 2012

News Daily News

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

February 21, 2012

News Daily News

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

L.A. McKeown

February 20, 2012

News Daily News

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

December 04, 2011

Advertisement

Un Registro Coreano Confirma la Superioridad de los Stents liberadores de Everolimus sobre los de Zotarolimus

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

SORT OUT IV: El Xience Aguanta el Tirón del Cypher en la Prevención de la Trombosis del Stent

SORT OUT III: Riesgo más alto de trombosis del stent muy tardía con Cypher en comparación con Endeavor

SORT OUT III: Higher Risk of Very Late Stent Thrombosis with Cypher vs. Endeavor

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

Xience V Noninferior to Cypher for Primary PCI

Meta-analysis: Less Stent Thrombosis at 2 Years with EES vs. Other DES

Meta Análisis: Menor Trombosis del Stent a los 2 Años con SLE que con Otro Tipo de SLF

Meta-analysis: Superior Efficacy with DES at No Cost to Safety

Meta Análisis: Superior Eficacia de los SLF sin poner en Peligro la Seguridad

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

SES Effective for Both Focal, Diffuse DES Restenosis

TCTMD’s Top 10 Most Popular News Stories From 2011

Stent Thrombosis Risk Lower with Xience vs. First-Generation DES

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content